ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NMDP Receives Record-Breaking $5 Million Philanthropic Gift

MINNEAPOLIS, March 19, 2024 (GLOBE NEWSWIRE) -- NMDPSM, formerly Be The Match, recently received a $5 million gift from the Moore family – the largest, single donation NMDP has ever received – to support the organization’s mission of advancing cell therapy research and treatments. The donation will help fund new research, donor recruitment efforts and patient grants.

A portion of the $5 million will fund recruitment, to continue adding young, ethnically diverse members to the NMDP Registry, the world’s most diverse registry of blood stem cell or marrow donors. Another part of the gift will support patient financial assistance, the number one patient-reported barrier to transplant.

The gift also fully funded this year’s Amy Strelzer Manasevit Research Program, one of the largest and most coveted grants in the transplant and cell therapy field. The grant is awarded to early-career researchers investigating preventions or treatments to life-threatening complications following all forms of cell therapy. NMDP recently named the two grant recipients whose research will help improve post-transplant outcomes.

“Generous supporters, like the Moore family, make it possible for NMDP to conduct ground-breaking research, support the next generation of investigators, offer patient assistance and grow our registry,” said Joy King, Chief Advancement Officer, NMDP. “With the Moore family’s generous contribution to NMDP, good goes a long way in advancing our mission, and we are extremely grateful. Philanthropy is critical to our work and helps more patients receive their life-saving cell therapy.”

In 2012, a young member of the Moore family received a blood stem cell transplant facilitated by NMDP. Since then, the Moore family has hosted recruitment drives, volunteered, and funded research, patient financial assistance, and recruitment programs.

Thanks in part to philanthropic gifts, NMDP has made monumental strides in accelerating progress and expanding access to treatment. The organization recently unveiled breakthrough research that will allow more patients with blood cancer or blood disorders to access life-saving cell therapy.

About NMDPSM
At NMDPSM, we believe each of us holds the key to curing blood cancers and disorders. As a global nonprofit leader in cell therapy, NMDP creates essential connections between researchers and supporters to inspire action and accelerate innovation to find life-saving cures. With the help of blood stem cell donors from the world’s most diverse registry and our extensive network of transplant partners, physicians and caregivers, we’re expanding access to treatment so that every patient can receive their life-saving cell therapy. NMDP. Find cures. Save lives.


Contact:
Erica Sevilla
NMDP
763-406-8758
esevilla@nmdp.org

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.